Search research articles
Contact Us
Filters
Showing results (101-110 of 336) with videos related to
Page
of 34
Sort By:
British Journal of Haematology
|
October 9, 2014
Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma
Daniel A Heinrich, Marc Weinkauf, Grit Hutter, et al.
Leukemia & Lymphoma
|
January 31, 2019
Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop
Brad S Kahl, Martin Dreyling, Leo I Gordon, et al.
Cancer Letters
|
March 7, 2006
Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia
Thomas Allgeier, Silke Garhammer, Elfriede Nössner, et al.
Leukemia & Lymphoma
|
February 12, 2014
Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop
Leo I Gordon, Steven H Bernstein, Pedro Jares, et al.
Annals of Hematology
|
December 15, 2015
Temsirolimus acts as additive with bendamustine in aggressive lymphoma
Anna-Katharina Zoellner, Tobias Weiglein, Grit Hutter, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 16, 2022
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective
Bernhard Moertl, Martin Dreyling, Christian Schmidt, et al.
Annals of Hematology
|
January 11, 2012
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma
Grit Hutter, Malte Rieken, Alessandro Pastore, et al.
Pharmacogenetics and Genomics
|
August 31, 2010
A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens
Heike Horn, Christiane Pott, Jörg Kalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2005
Treatment strategies in follicular lymphomas: current status and future perspectives
Wolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
British Journal of Haematology
|
November 18, 2025
A matching-adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor
Georg Heß, Toby A Eyre, Min-Hua Jen, et al.
Page
of 34
Search research articles
Search
Showing results (101-110 of 336) with videos related to
Sort By:
Page
of 34
British Journal of Haematology
|
October 9, 2014
Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma
Daniel A Heinrich, Marc Weinkauf, Grit Hutter, et al.
Leukemia & Lymphoma
|
January 31, 2019
Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop
Brad S Kahl, Martin Dreyling, Leo I Gordon, et al.
Cancer Letters
|
March 7, 2006
Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia
Thomas Allgeier, Silke Garhammer, Elfriede Nössner, et al.
Leukemia & Lymphoma
|
February 12, 2014
Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop
Leo I Gordon, Steven H Bernstein, Pedro Jares, et al.
Annals of Hematology
|
December 15, 2015
Temsirolimus acts as additive with bendamustine in aggressive lymphoma
Anna-Katharina Zoellner, Tobias Weiglein, Grit Hutter, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 16, 2022
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective
Bernhard Moertl, Martin Dreyling, Christian Schmidt, et al.
Annals of Hematology
|
January 11, 2012
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma
Grit Hutter, Malte Rieken, Alessandro Pastore, et al.
Pharmacogenetics and Genomics
|
August 31, 2010
A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens
Heike Horn, Christiane Pott, Jörg Kalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2005
Treatment strategies in follicular lymphomas: current status and future perspectives
Wolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
British Journal of Haematology
|
November 18, 2025
A matching-adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor
Georg Heß, Toby A Eyre, Min-Hua Jen, et al.
Page
of 34